iShares Biotechnology ETF (IBB)'s 30-day implied volatility (IV30) was 26.6% at the close on November 2, 2026, up from 25.9% the day before, against a 52-week range of 16.1% to 30.9%. Its 20-day historical volatility was 29.6%.
Data as of November 2, 2026.